Chronic Citalopram Administration Causes a Sustained Suppression of Serotonin Synthesis in the Mouse Forebrain

Gerard Honig, Minke E. Jongsma, Marieke C. G. van der Hart et al. · 2009

Read Chronic Citalopram Administration Causes a Sustained Suppression of Serotonin Synthesis in the Mouse Forebrain by Gerard Honig, Minke E. Jongsma, Marieke C. G. van der Hart et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006797.txt.

Description

Gerard Honig and his team gave mice a much-used mood drug for a long stretch in PLOS ONE in 2009. The drug is citalopram. It is an SSRI, a drug that blocks the reuptake of serotonin. Serotonin is a brain signal that shapes mood and acts. These drugs lift serotonin flow by blocking its cleanup. Vast numbers of people take them for low mood and fear.

Long use led the mouse forebrain to make less serotonin, and the drop lasted. So the brain made less of the signal while its cleanup stayed blocked. That shift may explain why such drugs act slowly or fade with time. It muddies the simple tale of how SSRIs help. The find counts for how long-term use of these drugs is judged.

Catalog record

CREATORGerard Honig, Minke E. Jongsma, Marieke C. G. van der Hart et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE63 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006797

Browse the full library · About the Tower of Babel